Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials

Clinical trial NCT04949841 · COMPLETED

Trial details

NCT number: NCT04949841
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hand Eczema

Start date: 2021-08-23
Primary completion: 2023-09-18
Enrollment: 801

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.